The AI medical imaging company has received an Australian Register of Therapeutic Goods Class IIa medical device certificate for ChestEye AI imaging service. Medical device certification paves the way for clinical use of ChestEye in the Australian market. ChestEye imaging suite is already certified by the CE mark. Oxipit received CE certification last February, enabling clinical ChestEye deployment in 32 European countries.
In Australian market ChestEye will be used to produce preliminary reports for chest X-Rays featuring no abnormality. The platform will mark no-finding chest X-ray images in the radiologist workflow, including only the images that the software can deem healthy with high confidence. The platform will then present a preliminary report, which can be augmented or approved after an assessment by the radiologist.
“In a clinical setting, especially in primary care facilities, approximately half of the chest X-rays feature no abnormality. Yet they still require reporting by a medical specialist. By identifying healthy patient X-rays with high confidence, ChestEye minimizes required radiologist intervention for report approval featuring no abnormalities,” notes CEO of Oxipit Gediminas Peksys.
ChestEye imaging suite can identify 75 radiological findings covering over 90% of radiological cases presented to a radiologist on a daily basis.
Earlier this year Oxipit ChestEye was selected as the winner in the prestigious World Summit Awards in healthcare and well-being category.
Let’s block ads! (Why?)
Transaction marks KKR’s first Global Impact investment in the Philippines MAKATI, Philippines--(BUSINESS WIRE)--KKR, a leading…
NEW YORK & SYDNEY--(BUSINESS WIRE)--Accenture (NYSE: ACN) has agreed to acquire Partners in Performance, a…
The next-generation high performance, energy efficient Edge AI accelerator addresses the latest Generative AI solutions…
TEDA TIANJIN, China--(BUSINESS WIRE)--Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code 002821.SZ/6821.HK) announced today that it…
TORONTO--(BUSINESS WIRE)--Maropost, the commerce software suite built for fast-growing commerce brands, announces two significant appointments…
Blockbuster Franchise with Over 850 Million Registered Players Worldwide TOKYO--(BUSINESS WIRE)--NEXON Co., Ltd. (Nexon) (3659.TO),…